Phase 1b Study Investigating the Association of NP137 With mFOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma
Latest Information Update: 23 Apr 2025
At a glance
- Drugs Fluorouracil (Primary) ; Irinotecan (Primary) ; Levofolinic acid (Primary) ; NP 137 (Primary) ; Oxaliplatin (Primary)
- Indications Adenocarcinoma; Pancreatic cancer; Pancreatic ductal carcinoma
- Focus Adverse reactions
- Acronyms LAP-NET1
Most Recent Events
- 18 Apr 2025 Planned End Date changed from 28 Mar 2027 to 16 Jun 2025.
- 12 Dec 2024 Status changed from recruiting to active, no longer recruiting.
- 19 Sep 2024 Planned End Date changed from 28 Nov 2025 to 28 Mar 2027.